Literature DB >> 26515618

Patterns of Weakness, Classification of Motor Neuron Disease, and Clinical Diagnosis of Sporadic Amyotrophic Lateral Sclerosis.

Jeffrey M Statland1, Richard J Barohn2, April L McVey2, Jonathan S Katz3, Mazen M Dimachkie2.   

Abstract

When approaching a patient with suspected motor neuron disease (MND), the pattern of weakness on examination helps distinguish MND from other diseases of peripheral nerves, the neuromuscular junction, or muscle. MND is a clinical diagnosis supported by findings on electrodiagnostic testing. MNDs exist on a spectrum, from a pure lower motor neuron to mixed upper and lower motor neuron to a pure upper motor neuron variant. Amyotrophic lateral sclerosis (ALS) is a progressive mixed upper and lower motor neuron disorder, most commonly sporadic, which is invariably fatal. This article describes a pattern approach to identifying MND and clinical features of sporadic ALS.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Lou Gehrig disease; Lower motor neuron; Motor neuron disease; Upper motor neuron

Mesh:

Year:  2015        PMID: 26515618      PMCID: PMC4629510          DOI: 10.1016/j.ncl.2015.07.006

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  28 in total

1.  Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology.

Authors:  W G Bradley; F Anderson; M Bromberg; L Gutmann; Y Harati; M Ross; R G Miller
Journal:  Neurology       Date:  2001-08-14       Impact factor: 9.910

Review 2.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

3.  ALSFRS-R score and its ratio: a useful predictor for ALS-progression.

Authors:  Katja Kollewe; Ulrike Mauss; Klaus Krampfl; Susanne Petri; Reinhard Dengler; Bahram Mohammadi
Journal:  J Neurol Sci       Date:  2008-08-21       Impact factor: 3.181

4.  El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors.

Authors:  B R Brooks
Journal:  J Neurol Sci       Date:  1994-07       Impact factor: 3.181

5.  Primary lateral sclerosis: A heterogeneous disorder composed of different subtypes?

Authors:  P Zhai; F Pagan; J Statland; J A Butman; M K Floeter
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

6.  Consensus statement for standard of care in spinal muscular atrophy.

Authors:  Ching H Wang; Richard S Finkel; Enrico S Bertini; Mary Schroth; Anita Simonds; Brenda Wong; Annie Aloysius; Leslie Morrison; Marion Main; Thomas O Crawford; Anthony Trela
Journal:  J Child Neurol       Date:  2007-08       Impact factor: 1.987

Review 7.  Electrodiagnostic criteria for diagnosis of ALS.

Authors:  Mamede de Carvalho; Reinhard Dengler; Andrew Eisen; John D England; Ryuji Kaji; Jun Kimura; Kerry Mills; Hiroshi Mitsumoto; Hiroyuki Nodera; Jeremy Shefner; Michael Swash
Journal:  Clin Neurophysiol       Date:  2007-12-27       Impact factor: 3.708

8.  Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997-2011.

Authors:  Kim Traxinger; Crystal Kelly; Brent A Johnson; Robert H Lyles; Jonathan D Glass
Journal:  Neurol Clin Pract       Date:  2013-08

Review 9.  Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R G Miller; C E Jackson; E J Kasarskis; J D England; D Forshew; W Johnston; S Kalra; J S Katz; H Mitsumoto; J Rosenfeld; C Shoesmith; M J Strong; S C Woolley
Journal:  Neurology       Date:  2009-10-13       Impact factor: 9.910

10.  Racial and ethnic differences among amyotrophic lateral sclerosis cases in the United States.

Authors:  Lindsay Rechtman; Heather Jordan; Laurie Wagner; D Kevin Horton; Wendy Kaye
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-12-08       Impact factor: 4.092

View more
  24 in total

1.  Targeting Age-Related Neurodegenerative Diseases by AAV-Mediated Gene Therapy.

Authors:  Umut Cagin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Recumbent stepping aerobic exercise in amyotrophic lateral sclerosis: a pilot study.

Authors:  Anjali Sivaramakrishnan; Sangeetha Madhavan
Journal:  Neurol Sci       Date:  2019-02-04       Impact factor: 3.307

3.  Arginine-rich dipeptide-repeat proteins as phase disruptors in C9-ALS/FTD.

Authors:  Hana M Odeh; James Shorter
Journal:  Emerg Top Life Sci       Date:  2020-12-11

Review 4.  Dysregulation of IGF-1/GLP-1 signaling in the progression of ALS: potential target activators and influences on neurological dysfunctions.

Authors:  Ambika Shandilya; Sidharth Mehan
Journal:  Neurol Sci       Date:  2021-05-21       Impact factor: 3.307

5.  A Neurologist's Practical Approach to Cognitive Impairment.

Authors:  Philip W Tipton; Gregory S Day; Neill Graff-Radford
Journal:  Semin Neurol       Date:  2021-11-26       Impact factor: 3.420

6.  FUS Mutation Causes Disordered Lipid Metabolism in Skeletal Muscle Associated with ALS.

Authors:  Binbin Zhou; Yilei Zheng; Xiaobing Li; Huifang Dong; Jiaxi Yu; Yang Zou; Min Zhu; Yanyan Yu; Xin Fang; Meihong Zhou; Wei Zhang; Yun Yuan; Zhaoxia Wang; Jianwen Deng; Daojun Hong
Journal:  Mol Neurobiol       Date:  2022-09-28       Impact factor: 5.682

7.  Awaji criteria for the diagnosis of amyotrophic lateral sclerosis in Hanoi, Vietnam.

Authors:  Tuan Van Nguyen; Tuan Anh Tran; Hinh Thi Vu
Journal:  Neurol Sci       Date:  2021-05-22       Impact factor: 3.307

Review 8.  The Enigmatic Role of C9ORF72 in Autophagy.

Authors:  Melissa Nassif; Ute Woehlbier; Patricio A Manque
Journal:  Front Neurosci       Date:  2017-08-03       Impact factor: 4.677

Review 9.  Copy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative Diseases.

Authors:  Matthew E R Butchbach
Journal:  Front Mol Biosci       Date:  2016-03-10

10.  Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort.

Authors:  Paul Talman; Thi Duong; Steve Vucic; Susan Mathers; Svetha Venkatesh; Robert Henderson; Dominic Rowe; David Schultz; Robert Edis; Merrilee Needham; Richard Macdonnell; Pamela McCombe; Carol Birks; Matthew Kiernan
Journal:  BMJ Open       Date:  2016-09-30       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.